首页> Clinical cancer research : an official journal of the American Association for Cancer Research> Molecular Characterization of NUT Carcinoma: A Report from the NUT Carcinoma Registry.

Molecular Characterization of NUT Carcinoma: A Report from the NUT Carcinoma Registry.

导出 OA

翻译打印收藏纠错

第一作者： Justin J,Kim

第一单位： Lowe Center and Division of Thoracic Oncology, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.

作者： Justin J,Kim ^[1] ; Sara A,Walton ^[1] ; Navin R,Mahadevan ^[2] ; Jessica,Haradon ^[1] ; Francesco,Paoloni ^[1] ; Paul K,Paik ^[3] ; Jamie E,Chaft ^[3] ; Robert,Hsu ^[4] ; Sarina A,Piha-Paul ^[5] ; Pasi A,Jänne ^[6] ; David A,Barbie ^[6] ; Lynette M,Sholl ^[7] ; Steven G,DuBois ^[8] ; Glenn J,Hanna ^[9] ; Geoffrey I,Shapiro ^[10] ; Christopher A,French ^[7] ; Jia,Luo ^[6]

作者单位： Lowe Center and Division of Thoracic Oncology, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts. ^[1] Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.;Department of Pathology, University of Michigan, Ann Arbor, Michigan. ^[2] Thoracic Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York. ^[3] Department of Internal Medicine, Division of Medical Oncology, University of Southern California/Norris Comprehensive Cancer Center, Los Angeles, California. ^[4] Department of Investigational Cancer Therapeutics, University of Texas MD Anderson Cancer Center, Houston, Texas. ^[5] Lowe Center and Division of Thoracic Oncology, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.;Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts. ^[6] Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts. ^[7] Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston, Massachusetts. ^[8] Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.;Division of Head and Neck Oncology, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.;Center for Cancer Therapeutic Innovation, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts. ^[9] Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.;Center for Cancer Therapeutic Innovation, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts. ^[10]